Loading clinical trials...
Loading clinical trials...
This single-arm, open-label, multi-center study will evaluate the safety and efficacy of vismodegib (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma. Patients will recei...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hoffmann-La Roche
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT05651828 · Advanced Basal Cell Carcinoma
NCT07144384 · Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma, and more
NCT07182240 · Basal Cell Carcinoma
Inst. de Oncologia Angel H. Roffo ; Servicio de Oncologia
Buenos Aires
Premier Specialists
Kogarah, New South Wales
Skin and Cancer Foundation Australia
Westmead, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions